Готові списки джерел за темами / Adjunctive therapy

Добірка наукової літератури з теми "Adjunctive therapy"

Автор: Grafiati
Опубліковано: 10 грудня 2022
Оновлено: 28 січня 2023

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Зміст

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Adjunctive therapy".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Статті в журналах з теми "Adjunctive therapy"

1

Miles, A. M., J. Fleishacker, G. Hyppolite, Z. H. Zhao, D. Distant, and E. A. Friedman. "ADJUNCTIVE UREMIA THERAPY." ASAIO Journal 42, no. 2 (March 1996): 90. http://dx.doi.org/10.1097/00002480-199603000-00340.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Miles, A. M., J. Fleishacker, G. Hyppolite, Z. H. Zhao, D. Distant, and E. A. Friedman. "ADJUNCTIVE UREMIA THERAPY." ASAIO Journal 42, no. 2 (April 1996): 90. http://dx.doi.org/10.1097/00002480-199604000-00341.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Cairns, J. A. "Reperfusion adjunctive therapy." CHEST Journal 99, no. 4 (April 1, 1991): 141S. http://dx.doi.org/10.1378/chest.99.4.141s.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Weinberg, Barry J., Damian DiCostanzo, and Mark J. Rosen. "Adjunctive Corticosteroid Therapy." AIDS Patient Care 9, no. 1 (February 1995): 4–6. http://dx.doi.org/10.1089/apc.1995.9.4.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Lamont, Leigh A., William J. Tranquilli, and Karol A. Mathews. "Adjunctive Analgesic Therapy." Veterinary Clinics of North America: Small Animal Practice 30, no. 4 (July 2000): 805–13. http://dx.doi.org/10.1016/s0195-5616(08)70008-1.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Morrison, John C., and Alan L. Robin. "Adjunctive Glaucoma Therapy." Ophthalmology 96, no. 1 (January 1989): 3–7. http://dx.doi.org/10.1016/s0161-6420(89)32943-5.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

CHRISTENSEN, GORDON J. "ADJUNCTIVE PERIODONTAL THERAPY." Journal of the American Dental Association 130, no. 6 (June 1999): 869–70. http://dx.doi.org/10.14219/jada.archive.1999.0313.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

CAIRNS, JOHN A. "Reperfusion Adjunctive Therapy: Heparin." Journal of Interventional Cardiology 3, no. 4 (December 1990): 217–23. http://dx.doi.org/10.1111/j.1540-8183.1990.tb00982.x.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Guberman, A. H. "Adjunctive therapy with benzodiazepines." Human Psychopharmacology: Clinical and Experimental 10, S1 (July 1995): S75—S77. http://dx.doi.org/10.1002/hup.470100711.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Arbo, Antonio. "Adjunctive therapy in bacterial meningitis." Revista del Instituto de Medicina Tropical 10, no. 2 (July 29, 2016): 1–3. http://dx.doi.org/10.18004/imt/20151021-3.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Дисертації з теми "Adjunctive therapy"

1

Massicotte, Eric M. "Adjunctive drug therapy for treatment of experimental hydrocephalus." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 2000. http://www.collectionscanada.ca/obj/s4/f2/dsk1/tape4/PQDD_0011/MQ53184.pdf.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Hatzimanolakis, Penny. "Photodynamics : is this a viable adjunctive periodontal therapy?" Thesis, University of British Columbia, 2009. http://hdl.handle.net/2429/7585.

Повний текст джерела
Анотація:
Objective: The aim of this study was to conduct a randomized in vivo clinical trial to assess the efficacy of a one time application of a phoactivated dye, methylene blue (PerioWaveTM) in treating chronic periodontal disease in humans. Material and Methods: Thirty five periodontally maintained subjects with moderate to severe chronic periodontitis were randomly divided into a control group with nonsurgical periodontal debridement (NSPD) only versus an experimental group with NSPD and antimicrobial photodynamic therapy (APT). All teeth in both groups received periodontal treatment comprising of scaling, root planing, ultrasonics and local anaesthesia. The experimental group had the qualifying sites (pockets depths greater than 4.4 mm and bleeding on probing (BOP)) treated with the PerioWaveTM system and compared to the control group. The primary endpoint was clinical attachment level (CAL) and secondary endpoints were pocket depth (PD) and BOP. The endpoints and plaque were evaluated at baseline, 6 and 12 weeks by a blinded examiner. Results: This study showed PerioWaveTM as a one time application of a cold diode laser with a wavelength of 670nm; a maximum power of 150mw; an average energy density of 20 J/cm²; a phenothiazine photosensitizer (methylene blue) in a concentration of 0.01% wt/vol; and at an optimal activation time of 60 seconds per mesiodistal surface had no statistical significance in the treated qualifying sites with regards to CAL (p=.69; p=.97) or PD (p=.14; p=.23) at 6 or 12 weeks after treatment over the NSPD group. However BOP did have a statistical significance over the control group at 6 weeks (p=.05) but not at 12 weeks (p=.47). Conclusions: In patients with advanced chronic periodontitis, CAL and PD did not show improvement with one time application of the PerioWaveTM photodynamic system over conventional NSPD. However, the lack of BOP did have a short time (6 weeks) reduction.
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Kirkman, Danielle Louise. "Exercise as adjunctive therapy in chronic kidney disease." Thesis, Bangor University, 2013. https://research.bangor.ac.uk/portal/en/theses/exercise-as-adjunctive-therapy-in-chronic-kidney-disease(a8f961d2-6026-429c-aa7d-e18a6ffef1bf).html.

Повний текст джерела
Анотація:
Background. Exercise is a natural medicine that has been prescribed for the prevention and management of chronic diseases, to enhance quality of life, improve health status and promote longevity. Current efforts to implement exercise as routine practice in the conventional renal replacement therapy population have been hampered by a lack of randomised controlled data. The aim of this thesis was to investigate the effect of exercise as an adjunctive therapy to enhance outcomes pertaining to renal transplantation, vascular access, haemodialysis adequacy and muscle wasting in Stage 4 and 5 Chronic Kidney Disease patients. It was hypothesised that randomised controlled trials employing gold standard outcome measures would reveal significant beneficial effects of exercise that are strongly associated with quality of life, hospitalisation and survival in this patient population. Reports. The first report presents a systematic literature review of exercise in the kidney transplant population. The largest positive effects were noted on intermediate outcomes such as aerobic fitness and muscle strength. Presumably these adaptations contributed to the trends observed for improvement in quality of life. Whether exercise impacts on outcomes associated with longevity of life requires further study. The rest of the thesis focused on patients receiving the more popular form of renal replacement therapy, haemodialysis. The first empirical study of the thesis, appertaining to vascular access, investigated the feasibility of implementing a post-operative forearm exercise intervention for arteriovenous fistula maturation. Exercise had no effect on primary outcomes measures of arterial diameter (95% Cl, -0.24 [-1.12; 0.51] mm) and venous diameter (95% Cl, 0.16 [-1.84; 1.24] mm). It was concluded that future randomized controlled trials should investigate a similar protocol implemented before arteriovenous fistula creation to enhance surgery success and maturation. The second randomised controlled trial explored the effect of intradialytic exercise, in comparison to the traditional prescription of increased dialysis time, to enhance dialysis adequacy and solute removal. Increased haemodialysis time, but not exercise, increased equilibrated Kt/V urea compared to control trials (Extra time vs. control: 95% Cl, 0.15 [0.05; 0.26], P < 0.05; exercise vs. control: 95% Cl, 0.03 [-0.05; 0.12], P > 0.05). Exercise, but not increased time, increased phosphate reduction ratio (exercise vs. control: 95% Cl, 8.6 [0.5; 16.7] %,p < 0.05; extra time vs. control: 95% Cl, 5.0 [-1.0; 11.1] %, p > 0.05). Thus intradialytic exercise cannot replace the traditional prescription of increased haemodialysis time for improving dialysis efficacy, but may be a useful adjunctive therapy for serum phosphate control. The third study implemented a randomised controlled trial of intradialytic progressive resistance training for treating muscle wasting. The primary outcome measure of thigh muscle volume, as measured by magnetic resonance imaging, significantly increased following 12 weeks of training compared to a sham exercise control (95% Cl, 193 [63; 324] cm3). Intradialytic resistance exercise elicited an anabolic and strength response in haemodialysis patients. However, a surprising lack of a change in functional capacity despite increased muscle mass warrants further investigation. Conclusion. The findings suggested that exercise had a beneficial effect on factors relating to outcomes in Stages 4 and 5 Chronic Kidney Disease patients. However, to ensure effectiveness of interventions and to maximize programme efficiency, careful consideration of basic exercise and physiological principles is required. Nevertheless, the observed benefits of exercising outweighed its risks, thus supporting the initiative for exercise prescription as an adjunctive therapy for the management of this disease state.
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Parrish, A. G. "Cost-effectiveness of nebulised ipratropium as adjunctive therapy in acute asthma." Master's thesis, University of Cape Town, 1993. http://hdl.handle.net/11427/24972.

Повний текст джерела
Анотація:
Aim: To determine whether the addition of nebulised ipratropium to the therapy of acute asthma leads to a cost-effective reduction in the mean duration of admission and time to maximum peak expiratory flow rate (PEFR). Method: Patients with an admission diagnosis of acute asthma were studied in a double-blind, placebo-controlled trial in which they received a standard therapeutic regimen of continuous intravenous aminophylline, 4-hourly fenoterol nebulisation, intravenous methylprednisolone 125mg 12-hourly, and, every four hours, either nebulised saline placebo or ipratropium bromide 500mcg in 3ml saline. Data on age, gender, initial and maximum PEFR, time to maximum PEFR, and duration of hospital stay was collected from the hospital record after discharge. Statistical techniques: 2-way contingency tables for categorical variables, 1-way ANOVA for treatment effects, and life-table analysis of the time till discharge. Results: Records of 279 of the 400 patients entered in the study were suitable for analysis after excluding re-admissions, non-asthmatics and incomplete records. Baseline comparisons of age and severity on presentation showed no significant differences. The trial group did not differ significantly from the control group with respect to either time to PEFR (respectively 21.11 hours (SD 14.3) versus 22.89 (SD 15.82)) or duration of admission (5.02 (SD 3.65) versus 5.38 (SD 3.13) 6-hour units). In a sub-group of patients (n=155) demonstrating more than 100% improvement in PEFR, the time to maximum PEFR was significantly shorter in the ipratropium group (20.35 hours SD 12.4) versus 25.20 hours (SD 17.0); p= 0.045). Conclusion: The addition of ipratropium bromide to a standard treatment regimen for acute asthma reduced the time to achieve maximum PEFR in a sub-group of patients with markedly reversible airflow limitation. Overall, however, the addition did not prove cost-effective.
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Bodnar, Sallyjane E. "Family therapy and creative visualisation : an adjunctive treatment for allergies in children." Thesis, University of British Columbia, 1990. http://hdl.handle.net/2429/29188.

Повний текст джерела
Анотація:
The purpose of the study was to explore the use of Creative Visualization in the context of Family Therapy for treatment of a family of a child with allergies. Based on a single-case research design, the study included pre- and posttest measures; baseline, continuous, and follow-up self-report of symptoms; plus examination of physician's clinical records to determine the efficacy of the intervention. A further purpose of the study was to explore the possible usefulness of a test being developed on the basis of the Psychosomatic Family Model, the Leuven Family Assessment, as an outcome measure. The subject family was an intact family with one adolescent daughter whose most important allergic symptom was poorly controlled asthma, at least partially due to noncompliance with medical advice. The measures included the Leuven Family Assessment, a measure based on the Psychosomatic Family Model, which has been developed for use with families of children with eating disorders; the Family Adaptability and Cohesion Scale (FACES III), a measure based on the Circumplex Family Model, which is a well-accepted measure of family functioning; symptom self-report; and consultation with the child's physician to report hospital admissions and emergency room visits. The baseline period was two weeks, the intervention consisted of two weeks of Relaxation Training and eight weekly meetings for combined Family Therapy and Creative Visualization, and the follow-up consisted of telephone contact with the symptomatic adolescent beginning fourteen weeks after the last family therapy session and continuing for eight weeks. Post-therapy results show a trend toward expected changes in family structure and functioning and marked improvement in the asthmatic symptoms of the adolescent. Creative Visualization is an intervention tool well worth further exploration in the context of family therapy; and the Leuven Family Assessment merits further investigation and development as an outcome measure.
Education, Faculty of
Educational and Counselling Psychology, and Special Education (ECPS), Department of
Graduate
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Yeung, Wing-kwan Rosa. "Adjunctive effect on hormone replacement therapy on periodontal treatment responses in postmenopausal women." Click to view the E-thesis via HKUTO, 2004. http://sunzi.lib.hku.hk/hkuto/record/B3765195X.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Yeung, Wing-kwan Rosa, and 楊穎筠. "Adjunctive effect on hormone replacement therapy on periodontal treatment responses in postmenopausal women." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2004. http://hub.hku.hk/bib/B3765195X.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Puligheddu, Monica Maria Francesca <1969&gt. "Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy (NFLE)." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2015. http://amsdottorato.unibo.it/7057/.

Повний текст джерела
Анотація:
Nocturnal Frontal Lobe Epilepsy (NFLE) is characterized by onset during infancy or childhood with persistence in adulthood, family history of similar nocturnal episodes simulating non-REM parasomnias (sleep terrors or sleepwalking), general absence of morphological substrates, often by normal interictal electroencephalographical recordings (EEGs) during wakefulness. A family history of epilepsy may be present with Mendelian autosomal dominant inheritance has been described in some families. Recent studies indicate the involvement of neuronal nicotinic acetylcholine receptors (nAChRs) in the molecular mechanisms of NFLE. Mutations in the genes encoding for the α4 (CHRNA4) and ß2 (CHRNB2) subunits of the nAChR induce changes in the biophysical properties of nAChR, resulting generally in a “gain of function”. Preclinical studies report that activation of a nuclear receptor called type peroxisome proliferator-activated receptor (PPAR-α) by endogenous molecules or by medications (e.g. fenofibrate) reduces the activity of the nAChR and, therefore, may decrease the frequency of seizures. Thus, we hypothesize that negative modulation of nAChRs might represent a therapeutic strategy to be explored for pharmacological treatment of this form of epilepsy, which only partially responds to conventional antiepileptic drugs. In fact, carbamazepine, the current medication for NFLE, abolishes the seizures only in one third of the patients. The aim of the project is: 1)_to verify the clinical efficacy of adjunctive therapy with fenofibrate in pharmacoresistant NFLE and ADNFLE patients; focousing on the analysis of the polysomnographic action of the PPAR- agonist (fenofibrate). 2)_to demonstrate the subtended mechanism of efficacy by means of electrophysiological and behavioral experiments in an animal model of the disease: particularly, transgenic mice carrying the mutation in the nAChR 4 subunit (Chrna4S252F) homologous to that found in the humans. Given that a PPAR-α agonist, FENOFIBRATE, already clinically utilized for lipid metabolism disorders, provides a promising therapeutic avenue in the treatment of NFLE\ADNFLE.
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Ruiz, Magaz Vanessa. "Efficacy of adjunctive Er,Cr:YSGG laser application following scaling and root planing in periodontally diseased patients." Doctoral thesis, Universitat Internacional de Catalunya, 2015. http://hdl.handle.net/10803/310948.

Повний текст джерела
Анотація:
Scientific rationale for study The literature about lasers in the field of periodontology is contradictory. The present study aimed at evaluating benefits of Er, Cr: YSGG laser irradiation following deep scaling compared to scaling alone in a randomized controlled clinical trial based on an appropriate sample size. Principal Findings The present study demonstrated that laser irradiation combined with conventional Sc/RP did not improve the clinical outcomes regarding probing pocket depth reduction and attachment level gain compared to Sc/RP alone. Practical implications Taken into account that lasers are expensive devices and no superior results can be expected by using them, their recommendation for clinical application is still questionable.
Justificació de l´estudi La literatura sobre l´ús de làser en el camp de la periodòncia és contradictori. Aquest estudi té com objectiu evaluar els beneficits de la irradiació amb làser d´Er,Cr:YSGG després de realitzar un raspat de les arrels comparat amb el raspat sense aplicar làser en un estudi clínic randomitzat amb un tamany mostral adequat. Resultats principals Aquest estudi ha demostrat que la irradiació de láser Er,Cr:YSGG combinada amb el tractament convencional de raspat I allisat radicular no millora les variables clíniques en la disminució de la profunditat de bossa i del augment del nivell d´inserció clínica. Implicacions pràctiques Tenint en compte que els aparells de làsers son costosos i que els resultats obtinguts no son superiors al tractament convencional, la recomanació d´aplicació clínica és a data d´avui encara qüestionable.
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Qian, Cheng. "The effect of angiotensin (1-7) on bone marrow stem cells adjunctive pharmacological therapy for cell transplantation in heart failure /." [S.l. : [Groningen : s.n.] ; University Library Groningen] [Host], 2008. http://irs.ub.rug.nl/ppn/.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Книги з теми "Adjunctive therapy"

1

Langilotti, Frank T. Adjunctive therapy. Glen Head, N.Y: New York Chiropractic College, 1985.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

L, Ziffer Robert, ed. Adjunctive techniques in family therapy. Orlando: Grune & Stratton, 1985.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

R, Bates Eric, ed. Thrombolysis and adjunctive therapy for acute myocardial infarction. New York: Dekker, 1993.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Michael, Lerner. Integral cancer therapy: A work in progress and adjunctive cancer therapies with a primary emphasis on intelligent and informed personal choice in the integration of conventional adjunctive and alternative treatment systems. Bolinas, Calif: Commonweal, 1985.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Langilotti, Frank T. Adjunctive Therapy: 1985 Edition. New York Chiropractic College, 1985.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Reffelmann, Thorsten, and Robert Kloner. Adjunctive Reperfusion Therapy Post-AMI. Oxford University Press, 2011. http://dx.doi.org/10.1093/med/9780199544769.003.0009.

Повний текст джерела
Анотація:
• Reperfusion of the occluded coronary artery in an ST-segment-elevation myocardial infarction is the most effective approach for reducing infarct size, preserving left ventricular ejection fraction, lowering the incidence and severity of congestive heart failure and improving prognosis• Hence, several pharmacologic agents intended to improve target vessel patency as an adjunct to thrombolysis or primary percutaneous coronary intervention have been shown to be beneficial in patients with reperfusion therapy for acute myocardial infarction, namely antiplatelet and anticoagulation agents• Animal investigations have suggested that coronary reperfusion may also result in undesirable cardiac alterations, termed ‘reperfusion injury’, such as reversible contractile dysfunction (‘stunning’), microvascular obstruction (‘no-reflow’), and in several studies the progression of myocardial necrosis (‘lethal reperfusion injury’)• Clinical investigations of various pharmacologic interventions as an adjunctive therapy to reperfusion to reduce final infarct size, the amount of contractile dysfunction and to improve prognosis have been mostly inconsistent; only a few interventions, e.g. adenosine and atrial natriuretic peptide seem to show promise at least in certain subgroups.
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Nortier, J. W. R. Nortier : adjunctive medical therapy pb Crs 2: Adjunctive medical therapy pb Crs 2. De Gruyter, Inc., 2019.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Cummings, Nicholas A., and William O'Donohue. Evidence-Based Adjunctive Treatments. Elsevier Science & Technology Books, 2011.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Woolf, Eric C., and Adrienne C. Scheck. Ketogenic Diet as Adjunctive Therapy for Malignant Brain Cancer. Edited by Jong M. Rho. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780190497996.003.0013.

Повний текст джерела
Анотація:
Malignant brain tumors are devastating, and increased survival requires new therapeutic modalities. Metabolic dysregulation results in an increased need for glucose in tumor cells, suggesting that reduced tumor growth could be achieved with decreased glucose availability either through pharmacological means or use of a high-fat, low-carbohydrate ketogenic diet (KD). KD provides increased blood ketones to support energy needs of normal tissues and has been shown to reduce tumor growth, angiogenesis, inflammation, peritumoral edema, migration, and invasion. Furthermore, this diet can enhance the activity of radiation and chemotherapy in a mouse model of glioma, thus increasing survival. In vitro studies indicate that increasing ketones in the absence of glucose reduction can also inhibit cell growth and potentiate the effects of radiation. Thus, emerging data provide strong support for the use of KD in the treatment of malignant gliomas and thus far has led to a limited number of clinical trials.
Стилі APA, Harvard, Vancouver, ISO та ін.
10

E, Sobel Burton, and Collen D, eds. Coronary thrombolysis in perspective: Principles underlying conjunctive and adjunctive therapy. New York: M.Dekker, 1993.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Частини книг з теми "Adjunctive therapy"

1

Han, Seung-Kyu. "Adjunctive Therapy." In Innovations and Advances in Wound Healing, 249–62. Berlin, Heidelberg: Springer Berlin Heidelberg, 2016. http://dx.doi.org/10.1007/978-3-662-46587-5_11.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Levi, Paul A., Y. Natalie Jeong, Robert J. Rudy, and Daniel K. Coleman. "Adjunctive Therapy." In Non-Surgical Control of Periodontal Diseases, 163–73. Berlin, Heidelberg: Springer Berlin Heidelberg, 2016. http://dx.doi.org/10.1007/978-3-662-46623-0_7.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Whitson, Jess T. "Choosing Adjunctive Glaucoma Therapy." In The Glaucoma Book, 629–41. New York, NY: Springer New York, 2010. http://dx.doi.org/10.1007/978-0-387-76700-0_52.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Henry, Philip D., and Antonio Pacifico. "Adjunctive Antiarrhythmic Drug Therapy." In Developments in Cardiovascular Medicine, 245–57. Boston, MA: Springer US, 2002. http://dx.doi.org/10.1007/978-1-4615-1055-0_10.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Damas, P., P. Mahieu, and A. Adam. "Fibronectin: Adjunctive Therapy in Sepsis." In Septic Shock, 276–82. Berlin, Heidelberg: Springer Berlin Heidelberg, 1987. http://dx.doi.org/10.1007/978-3-642-83108-9_23.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Nibali, Luigi, and Elena Calciolari. "Innovative and Adjunctive Furcation Therapy." In Diagnosis and Treatment of Furcation-Involved Teeth, 191–207. Chichester, UK: John Wiley & Sons, Ltd, 2018. http://dx.doi.org/10.1002/9781119270638.ch10.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Dhawan, Amit. "Adjunctive Therapy in Oral Cancer." In Oral and Maxillofacial Surgery for the Clinician, 1903–13. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-15-1346-6_84.

Повний текст джерела
Анотація:
AbstractOral squamous cell carcinoma is the third most common cancer in Indian subcontinent affecting people with lower socioeconomic status. Due to inadequate screening facilities and lack of awareness among individuals most of the oral cancer cases are detected at an advanced stage. As early stage oral squamous cell carcinoma patients can be treated with single modality treatment (surgery or radical radiotherapy), multimodality regimen (surgery followed by concurrent chemoradiation) is adopted for high risk advanced stage cancers with multiple adverse features like extra nodal extension, lymphovascular invasion and perineural spread. The chapter outlines the principles of adjunctive therapy in oral cancer patients with special reference to different techniques, indications of radiotherapy and role of chemotherapeutic regimes in improving the overall survival of advanced stage oral cancer patients.
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Asai, Yasufumi, and Hiroshi Dohgomori. "Hyperbaric Oxygenation as an Adjunctive Therapy." In Hyperbaric Oxygenation Therapy, 55–65. Singapore: Springer Singapore, 2019. http://dx.doi.org/10.1007/978-981-13-7836-2_4.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Russell, Christy A. "Adjunctive Systemic Therapy for Breast Cancer." In Breast Care, 225–39. New York, NY: Springer New York, 1999. http://dx.doi.org/10.1007/978-1-4612-2144-9_23.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Girardis, Massimo, Giulia Serafini, and Ilaria Cavazzuti. "Immunoglobulin as Adjunctive Therapy in Sepsis." In Anaesthesia, Pharmacology, Intensive Care and Emergency A.P.I.C.E., 193–99. Milano: Springer Milan, 2013. http://dx.doi.org/10.1007/978-88-470-5516-2_15.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "Adjunctive therapy"

1

Spangenthal, S. "Guaifenesin as Adjunctive Therapy in Chronic Cough: A Case Study." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3746.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Kobayashi, Kanako, Shuichi Yano, and Toshikazu Ikeda. "Adjunctive Corticosteroid Therapy For Adverse Drug Reactions Due To Antituberculous Drugs." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a4913.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Guberek, Rhona, Sheila Schneiberg, Patricia McKinley, Felicia Cosentino, Mindy F. Levin, and Heidi Sveistrup. "Virtual reality as adjunctive therapy for upper limb rehabilitation in cerebral palsy." In 2009 Virtual Rehabilitation International Conference. IEEE, 2009. http://dx.doi.org/10.1109/icvr.2009.5174257.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Nyamekye, Isaac, Jean R. McEwan, Alexander J. MacRobert, Christopher C. R. Bishop, and Stephen G. Bown. "Adjunctive arterial injury and photodynamic therapy with aluminium disulphonated phthalocyanine inhibits intimal hyperplasia." In International Symposium on Biomedical Optics Europe '94, edited by Stephen G. Bown, J. Escourrou, Frank Frank, Herbert J. Geschwind, Guilhem Godlewski, Frederic Laffitte, and Hans H. Scherer. SPIE, 1994. http://dx.doi.org/10.1117/12.197583.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Clark, Brendan J., Marc Moss, Katie H. Overdier, Angela Keniston, Ellen L. Burnham, Michael Doody, and Ivor S. Douglas. "Dexmedetomidine As An Adjunctive Therapy For Critically Ill Patients With Severe Alcohol Withdrawal Syndrome." In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a3186.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Suda, M., S. Ohde, T. Tsuda, M. Kishimoto, and M. Okada. "SAT0118 Safety and efficacy of alternate-day corticosteroids as adjunctive therapy in rheumatoid arthritis." In Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.4160.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Anadani, M., S. Ajinky, A. Alawieh, A. Chatterjee, J. Vargas, R. Turner, A. Turk, M. Chaudry, and A. Spiotta. "E-161 Intra-arterial tissue plasminogen activator is a safe adjunctive therapy to mechanical thrombectomy." In SNIS 15TH ANNUAL MEETING, July 23–26, 2018, Hilton San Francisco Union Square San Francisco, CA. BMA House, Tavistock Square, London, WC1H 9JR: BMJ Publishing Group Ltd., 2018. http://dx.doi.org/10.1136/neurintsurg-2018-snis.237.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Wu, Qing, Qingdong Huang, Zhuomei Chen, Yongbao Cao, Genxiang Mao, Jianhua Dong, Sanying Wang, Xiaoling Lv, and Guofu Wang. "Effects of Cinnamomum Camphora Forest Environment on Elderly Patients with Hypertension: Implications for Adjunctive Therapy." In Proceedings of the 2nd Symposium on Health and Education 2019 (SOHE 2019). Paris, France: Atlantis Press, 2019. http://dx.doi.org/10.2991/sohe-19.2019.34.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

O'Connor, S. A. "Vagus nerve stimulation as an adjunctive therapy in the treatment of patients with medically intractable epilepsy." In IEE Seminar on Electrical Engineering and Epilepsy: A Successful Partnership in conjunction with the Epilepsy Research Foundation. IEE, 1998. http://dx.doi.org/10.1049/ic:19980708.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Sexton, C., and K. Drygas. "Description of Intravenous Photobiomodulation Therapy as an Adjunctive Treatment in 16 Dogs with Intervertebral Disc Disease." In Abstracts of the 6th World Veterinary Orthopedic Congress. Georg Thieme Verlag KG, 2022. http://dx.doi.org/10.1055/s-0042-1758307.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Звіти організацій з теми "Adjunctive therapy"

1

Zhang, Yanli. Adjunctive Rifampin Therapy For Diabetic Foot Osteomyelitis: A Systematic Review and Meta-Analysis. INPLASY - International Platform of Registered Systematic Review Protocols, April 2020. http://dx.doi.org/10.37766/inplasy2020.4.0058.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Zhang, Yanli. Adjunctive rifampin therapy for diabetic foot osteomyelitis: a protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review Protocols, April 2020. http://dx.doi.org/10.37766/inplasy2020.4.0084.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Dai, Qianxiang. Effectiveness and Safety of Adjunctive Traditional Chinese Medicine Therapy for Constipation after Cancer Chemotherapy：A Protocol Systematic Review and Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, July 2020. http://dx.doi.org/10.37766/inplasy2020.7.0027.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Qin, Jun-Ping, Hua Zhou, Yuan Zhu, Yuan Xu, Bin Du, and Hui-Bin Huang. Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: A systematic review and meta-analysis of randomised controlled studies. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, July 2020. http://dx.doi.org/10.37766/inplasy2020.7.0045.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Qiao, Lijun, Yiqiang Xie, Xiujuan Xie, Hongming Hu, Tianpeng Ma, Brian Oliver, and Hui Che. The efficacy of adjunctive therapy using Huanshao Dan (HSD) in patients with dementia: A protocol for systematic review and meta-analysis of randomized controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, December 2020. http://dx.doi.org/10.37766/inplasy2020.12.0082.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Xu, Chunhong, Xinxin Guo, Changhui Zhou, and Hualing Zhang. Brucea javanica oil emulsion injection (BJOEI) as an adjunctive therapy for patients with advanced colorectal carcinoma: A protocol for a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, June 2020. http://dx.doi.org/10.37766/inplasy2020.6.0014.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Також вас можуть зацікавити розширені добірки на тему "Adjunctive therapy" для конкретних типів джерел:
Статті в журналах Дисертації Книги
Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!

До бібліографії